PP
Therapeutic Areas
AMLo Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AMBLor® | Early-stage Melanoma Prognosis | Pre-clinical/Validation |
| Prognostic Test | Cutaneous Squamous Cell Carcinoma (cSCC) | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| AMBLor® | Early-stage Melanoma Prognosis | Pre-clinical/Validation |
| Prognostic Test | Cutaneous Squamous Cell Carcinoma (cSCC) | Pre-clinical |